<DOC>
	<DOC>NCT00202371</DOC>
	<brief_summary>The goal of this study was to compare a restrictive RBC transfusion policy (a Hb transfusion trigger: 7.2 gr/dl) with a more liberal RBC transfusion policy (a Hb transfusion trigger: 9.6 gr/dl) on physical fatigue.</brief_summary>
	<brief_title>Transfusion Effects in Myelodysplastic Patients: Limiting Exposure</brief_title>
	<detailed_description>The goal of this study was to compare a restrictive RBC transfusion policy (a Hb transfusion trigger of 7.2 gr/dl) with a more liberal RBC transfusion policy (a Hb transfusion trigger of 9.6 gr/dl) on physical fatigue.</detailed_description>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>diagnosis myelodysplastic syndrome (primary or secondary) based on cytopenia in at least 1 cell line + dysplasia in 2 cell lines (and no other cause (especially deficiencies)) and a pathologic anatomic diagnosis after bone marrow punction. refractory anaemia (RA): blood: ≤ 1% blasts, ≤ 1 x 109 monocytes; bone marrow: &lt; 5% blasts, ringed sideroblasts ≤ 15% of the erythroid cells refractory anaemia with ringed sideroblasts (RARS): blood: ≤ 1% blasts, ≤ 1 x 109 monocytes; bone marrow: &lt; 5% blasts, ringed sideroblasts &gt; 15% of the erythroid cells refractory anaemia with excess blasts (RAEB): blood: &lt; 5% blasts, ≤ 1 x 109 monocytes; bone marrow: blasts ≥ 5 ≤ 20% chronic myelomonocytic leukaemia (CMML): blood: &gt;1 x 109/l monocytes, &lt;5% blasts; bone marrow: blasts &lt; 20%, increase of the monocytic component erythrocyte transfusion need working knowledge of the national language written consent for participating this study (informed consent) candidate for bone marrow or organ transplantation medication: growth factors (GMCSF), or EPO patients who will receive an intensive chemotherapeutic treatment with a cytopenia, expected longer than 2 weeks refractory anaemia with excess blasts in transformation (RAEBt): blood: ≥ 5% blasts or Auer rods; bone marrow: or blasts &gt; 20 &lt; 30% or Auer rods pregnancy at the moment of inclusion patients with congenital severe haemolytic anaemia, like thalassemia or sickle cell anaemia patients with AIDS or a severe congenital or acquired (e.g. iatrogenic) immunological disorder severe active infections at the moment of inclusion severe cardiac, pulmonal, neurological, metabolic or psychiatric disease at the moment of inclusion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>MDS, Fatigue, RBC transfusion</keyword>
</DOC>